AdaptHealth (NASDAQ:AHCO) Stock

AdaptHealth

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Wall Street

News

Price Target

Markets

Analyst Ratings

Trading Ideas

AHCO

These Analysts Lower Their Forecasts On AdaptHealth Following Weak Sales

Health Care

Small Cap

General

Philips (NYSE: PHG) is leaving no stone unturned to bolster its patient monitoring solutions portfolio on the back of recent collaborations.
In this regard, the company partnered with smartQare to integrate the latter&#39;s viQtor solution into its clinical patient monitoring platforms.


Philips (PHG) Boosts Patient Monitoring With SmartQare Deal

Penny Stocks

Intraday Update

Movers

ALPP

AULT

BBAI

BEAM

BIOR

BLUE

CARG

CDXS

CLDI

CLVT

CXAI

DNLI

DORM

EGIO

ELWS

FEAM

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HSII

IFBD

JANX

LGND

LUNR

MICS

NERV

NRXP

NVCR

PEGY

PRGO

PRIM

PRST

PTLO

PUBM

PYXS

SOUN

STGW

STRL

TBIO

TMDX

TREE

TWKS

VKTX

WDAY

WETG

Shares of  Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

AdaptHealth Corp

Did you know there's a way to predict the S&amp;P 500 with an ~85% correlation?
Sounds insane, but it's true.
Here's the surprising logic behind my claim:
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="936" height="621" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/19192221/image-3-9.png" alt="" class="wp-image-6097" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/19192221/image-3-9.png 936w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/19192221/image-3-9-300x199.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/19192221/image-3-9-768x510.png 768w" sizes="(max-width: 936px) 100vw, 936px" /></figure>
When investors look for long-term bullish S&amp;P 500 signals, they look at:
U.S CPI
U.S. interest rates
U.S. M2 supply (relatively liquid assets in the U.S economy)
This is a mistake.
Although these metrics matter, there's something we commonly forget.
Unlike most countries, the U.S. stock market is global.
German citizens rarely invest in Japanese stocks.
But many will invest in Nvidia, Apple, Microsoft, etc.
When central banks print money, it enters the economy of that respective country.
A portion of that money goes to citizens who buy food, shelter, clothing, etc.
However, some of them will invest their cash into assets.
A sizable portion specifically goes into the S&amp;P or S&amp;P-included companies.
That's why, if you're investing in the S&amp;P, you can't just focus on U.S. liquidity.
You need to focus on global liquidity instead.
The problem is global liquidity is hard to measure.
Combining M2 and interest rate data from the world's central banks isn't easy.
That's why financial data platforms like Ycharts and TradingView don't have a global liquidity metric.
This is why investors typically track GL from the 5 biggest central banks.
Specifically the:
Bank of Japan
Federal Reserve
Bank of England
European Central Bank
People's Bank of China
These are the most important central banks in the world, and tracking their efforts isn't difficult.
This is where most investors go wrong, when they exclusively track the Fed's monetary policies to predict the S&amp;P's long-term outlook.
But the S&amp;P receives inflows from across the globe.
That's why the decisions of the BoJ, BoE, ECB, and PBoC collectively matter more than the Federal Reserve alone.
Thanks to the U.S. stock market&#8217;s global status, global liquidity is highly correlated.
Popular U.S. stock indexes like the NASDAQ, for example, have a 95% correlation.
Whereas the S&amp;P has an ~85% correlation.
This chart speaks volumes.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="936" height="520" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/19192220/image-1.jpeg" alt="" class="wp-image-6096" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/19192220/image-1.jpeg 936w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/19192220/image-1-300x167.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/02/19192220/image-1-768x427.jpeg 768w" sizes="(max-width: 936px) 100vw, 936px" /></figure>
However, during bull markets, global liquidity sometimes decouples from the S&amp;P.
Particularly when there's particularly bullish news and the market gets excited.
Trump's election victory was a great example of this.
Politics aside, Trump has always been bullish for stocks.
The same can be said about bearish black swan events.
2008, the initial COVID scare, Yen carry trade, Deepseek, etc.
Bullish and bearish signals decouple the market from global liquidity.
But it always realigns.
It's important to remember that there's a delay between global liquidity and the stock market.
It takes time for liquidity to flow into assets and inflate prices.
Liquidity → stocks – fewer shares → lower supply → prices rise
What's the moral of the story?
Don't just analyze U.S. monetary policies.
Monitor the policies of the biggest central banks in the world.
With a delay, you can reliably predict the movements of major U.S. indexes.
&#x2A;&#x2A;
Hey there!
Welcome to the WOLF Financial Newsletter.
Join over 13,000 savvy investors building wealth and mastering advanced investing strategies live on Twitter Spaces. Subscribe below to be part of the action:
<a href="https://marketmadness-newsletter.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Subscribe</a>
WOLF Financial has driven liquidity, user growth, and brand awareness across TradFi and Crypto through marketing, advisory, and partnership services. See more&nbsp;<a href="https://wolf.financial/?utm_source=marketmadness-newsletter.beehiiv.com&amp;utm_medium=referral&amp;utm_campaign=the-rich-predict-the-s-p-year-after-year" target="_blank" rel="noreferrer noopener">Here</a>.
Looking to take your investing game to the next level?
Download the Blossom investing app to converse with 100k+ investors.
Plus, you'll get a peak at my investment portfolio. It's free — give it a try:&nbsp;<a href="https://www.blossomsocial.com/wolffinancial?utm_source=marketmadness-newsletter.beehiiv.com&amp;utm_medium=referral&amp;utm_campaign=the-rich-predict-the-s-p-year-after-year" target="_blank" rel="noreferrer noopener">https://www.blossomsocial.com/wolffinancial</a>

Equities

Large Cap

Broad U.S. Equity ETFs

Exclusives

There's a way to predict the S&P 500 with an 85% correlation!

Bank of America's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) short percent of float has fallen 20.0% since its last report. The company recently reported that it has 57.75 million shares sold short, which is 0.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.55 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Bank of America Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739995228_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Bank of America has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Bank of America's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Bank of America's peer group average for short interest as a percentage of float is 1.09%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Bank of America?

SentinelOne's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) short percent of float has risen 5.64% since its last report. The company recently reported that it has 13.00 million shares sold short, which is 4.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.31 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>SentinelOne Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739995222_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for SentinelOne has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing SentinelOne's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, SentinelOne's peer group average for short interest as a percentage of float is 5.24%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is SentinelOne Gaining or Losing Market Support?

KLA's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NYSE">KLAC</a>) short percent of float has fallen 14.53% since its last report. The company recently reported that it has 2.66 million shares sold short, which is 2.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.92 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>KLA Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739995217_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for KLA has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing KLA's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, KLA's peer group average for short interest as a percentage of float is 9.20%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

KLAC

Peering Into KLA's Recent Short Interest

President Donald Trump's plans to place tariffs on imported goods from several countries, including China, could cause retaliation <a href="https://www.benzinga.com/news/global/25/02/43442219/why-beer-tequila-avocados-cars-iphone-prices-could-rise-trumps-tariffs-on-canada-mexico-china-to-hurt-several-sectors">from other nations.</a>
A recent Benzinga poll shows which companies could be hurt by Trump's tariff plans in China.
What Happened: Trump has targeted China, Canada and Mexico with <a href="https://www.benzinga.com/25/02/43805852/trump-shakes-global-trade-with-25-auto-chip-and-pharma-tariffs-announcement-asian-stocks-pare-their-five-day-rally">tariffs or threats of tariffs</a> since taking office in January.
China has been Trump&#8217;s favorite target, and the tariffs and threats of additional tariffs could hurt relations with the country.
Higher prices to import items from China could also hurt consumers if costs are passed from companies down the line.
Benzinga recently polled readers on which company could be most vulnerable to Trump&#8217;s China tariffs.
"Which stock is most at risk from Trump's China tariffs?" Benzinga asked.
The results were:
<ul>
<li>Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), supply chain reliance on China: 35%</li>
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), chip exports facing restrictions: 28%</li>
<li>Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), China factory and exports: 28%</li>
<li>Boeing Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), aircraft sales to China: 9%</li>
</ul>
Apple was the top choice in the poll, and the company was viewed as the most likely to be at risk from tariffs on China.
Tesla and Nvidia tied for second place, which comes as both companies face pressure in the country.
Read Also: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43041374/exclusive-how-high-will-sp-500-go-under-donald-trump-in-2025-readers-are-optimistic-26-say-this">EXCLUSIVE: How High Will S&amp;P 500 Go Under Donald Trump In 2025? Readers Are Optimistic, 26% Say This…</a>
Why It's Important: Benzinga <a href="https://www.benzinga.com/news/global/25/02/43712690/exclusive-will-trumps-chinese-tariffs-help-or-hurt-americas-economy-54-say-this">recently polled readers </a>to see if they think the tariffs on China will be good or bad for the American economy.
&#8220;Will Trump&#8217;s tariffs on China help or hurt the U.S. economy?&#8221; Benzinga asked.
The results were:
<ul>
<li>Hurt businesses and consumers: 54%</li>
<li>Help the economy: 36%</li>
<li>No real impact: 10%</li>
</ul>
Most respondents said that tariffs on China will hurt businesses and consumers in America.
While Trump has called the tariff moves a way to fight trade imbalances, other countries have threatened America with retaliatory measures, such as tariffs or other measures. The Wall Street Journal said China was looking to target American companies with antitrust concerns. The list of companies China could target includes Nvidia, Apple, Broadcom, and Alphabet.
According to a new report, China is now<a href="https://www.benzinga.com/news/global/25/02/43600852/china-sets-sights-on-us-tech-companies-as-trade-tensions-rise" target="_blank" rel="noopener"> turning its attention </a>to targeting American technology companies as trade relations escalate.
The Wall Street Journal reported that China is considering targeting American tech companies with antitrust concerns. China could target Nvidia, Apple, Broadcom, and Alphabet.  
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/02/43795579/warren-buffett-unfazed-by-trumps-tariff-threats-oracle-of-omaha-bets-on-mexico-beer">Warren Buffett Unfazed By Trump&#8217;s Tariff Threats: Oracle Of Omaha Bets On Mexico, Beer</a></li>
</ul>
The study was conducted by Benzinga from Feb. 11, 2025 through Feb. 12, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 92 adults.
Photo: Shutterstock

Politics

AAPL

NVDA

TSLA

EXCLUSIVE: Apple, Nvidia, Tesla Or Boeing? Which Company Faces the Biggest Risk From Trump's China Tariffs — 35% Say This Stock

Wall Street expects Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) to report 64 cents in earnings per share when fourth-quarter financials are released <a href="https://www.benzinga.com/calendars/earnings?tickers=WMT" target="_blank" rel="noreferrer noopener">before market hours</a> on Thursday. 
 Analysts also expect the retailer to report $180.25 billion in revenues.
The stock is up 76.94% over the past year, 15.24% year-to-date.
Let&#8217;s look at what the charts indicate for Walmart stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com//node/43820201">Walmart Q4 Earnings Preview: Revenue Beat Streak On The Line, Expert Advises Long-Term Holders To &#8216;Enjoy The Ride&#8217;</a>
<h2 class="wp-block-heading">Walmart Stock Bullish Ahead Of Q4 Earnings</h2>
Walmart stock is exhibiting strong bullish momentum, with its share price trading above key moving averages. Currently, the company&#8217;s stock is positioned above its five-day, 20-day and 50-day exponential moving averages, signaling sustained buying pressure.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="629" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19133637/Screenshot-2025-02-20-at-12.02.14-AM.png" alt="" class="wp-image-789668" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19133637/Screenshot-2025-02-20-at-12.02.14-AM.png 629w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19133637/Screenshot-2025-02-20-at-12.02.14-AM-300x233.png 300w" sizes="(max-width: 629px) 100vw, 629px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022025&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
Walmart stock price of $103.69 sits comfortably above its eight-day simple moving average of $103.34, its 20-day simple moving average of $100.16 and its 50-day simple moving average of $95.63—all reinforcing a bullish trend. 
Additionally, Walmart's price remains well above its 200-day simple moving average of $79.74, further solidifying its long-term uptrend.
Momentum indicators also confirm this strength. The Moving Average Convergence Divergence (MACD) indicator stands at 2.87, a bullish signal suggesting continued upward momentum. Meanwhile, Walmart's Relative Strength Index (RSI) is at 69.10, nearing overbought territory but still indicating strong demand. 
As long as Walmart stock remains above these key technical levels, the stock is poised to maintain its bullish trajectory.
<h2 class="wp-block-heading">Walmart Analysts See 10% Upside</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/WMT/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on Walmart stock stands at a Buy currently with a price target of $102.07. The latest analyst ratings from Piper Sandler, Baird and Barclays imply a 9.50% upside for WMT stock, with a $113.67 average target.
Stock Price Action: Walmart stock was trading at $103.64 at the time of publication.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com//node/43811563">How To Earn $500 A Month From Walmart Stock Ahead Of Q4 Earnings</a></li>
</ul>
Image: Shutterstock

Technicals

Previews

Walmart Stock Bullish Ahead Of Q4 Earnings: Is Upside Already Priced In?

Shares of defense stocks are trading lower after a Washington Post report stated that the Trump administration ordered the Pentagon to plan for budget cuts.

<a href="https://www.washingtonpost.com/national-security/2025/02/19/trump-pentagon-budget-cuts/" title="https://www.washingtonpost.com/national-security/2025/02/19/trump-pentagon-budget-cuts/">https://www.washingtonpost.com/national-security/2025/02/19/trump-pentagon-budget-cuts/</a>

Macro Economic Events

Economics

'Trump Administration Orders Pentagon To Plan For Sweeping Budget Cuts; Orders Pentagon To Develop Plans For 8% Budget Cut In Each Of The Next 5-Years' - Washington Post

Occidental Petroleum Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) shares are moving higher on Wednesday as oil prices rise following a drone attack on a Russian pipeline, which could <a href="https://www.benzinga.com//node/43817326">weaken supply</a>.
The Details: The drone attack, which took place on Monday, targeted the Kropotkinskaya station located in Krasnodar, according to Reuters. The Kropotkinskaya station is the largest pumping station on the pipeline in Russia and is responsible for pumping about 1% of global crude oil supply.
The Caspian Pipeline Consortium oversees the pipeline and, as of Monday, has not identified those responsible for the attack. However, it confirmed that the Kropotkinskaya facility was shut down, and crude oil flow through the Tengiz-Novorossiysk pipeline system was being maintained at reduced rates, bypassing the pumping station.
Deputy chairman of Russia&#8217;s Security Council Dmitry Medvedev stated, &#8220;Ukrainian drones attacked a pumping station that provides oil transportation through the main oil pipeline of the Caspian Pipeline Consortium. A blow to an oil consortium could stop oil pumping, unbalance the market, increase oil price spikes and cause direct damage to American companies.&#8221;
Furthermore, Medvedev said that Ukraine's attack on a pipeline partially owned by U.S. companies was a blow against President Donald Trump, who has sought lower oil prices. He added that it remained to be seen how Trump would respond.
Occidental shares may be rising following the drone attack, as reduced supply could drive up prices, potentially boosting profits. The attack may also heighten concerns over geopolitical tensions, prompting investors to buy oil stocks as a hedge against future supply uncertainty.
What Else: Occidental reported earnings for the 2024 fiscal-year fourth-quarter after the market closed on Tuesday. The company reported adjusted earnings per share of 80 cents, beating analysts&#8217; estimate of 70 cents. In addition, it reported sales of $6.83 billion, missing analysts&#8217; estimate of $7.05 billion.
Additionally, Occidental announced it achieved its near-term debt repayment target of $4.5 billion in the fourth-quarter. In the 2025 first-quarter, it signed two agreements to divest upstream assets for a combined total of $1.2 billion.
Related Link: <a href="https://www.benzinga.com/25/02/43821108/garmin-posts-better-than-expected-results-joins-solaredge-technologies-compass-appian-and-other-big-stocks-moving-higher-on-wednesday">Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday</a>
OXY Price Action: At the time of writing, Occidental shares are trading 4.22% higher at $50.90, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

What's Going On With Occidental Petroleum Stock Wednesday?

President Donald Trump continues to plan and place tariffs on imported goods from several countries, due to what he calls an unfair trade balance <a href="https://www.benzinga.com/news/global/25/02/43442219/why-beer-tequila-avocados-cars-iphone-prices-could-rise-trumps-tariffs-on-canada-mexico-china-to-hurt-several-sectors">with other nations.</a>
A recent Benzinga poll shows what impact Trump's tariffs could have on the stock market.
What Happened: On Tuesday, Trump said he plans <a href="https://www.benzinga.com/25/02/43805852/trump-shakes-global-trade-with-25-auto-chip-and-pharma-tariffs-announcement-asian-stocks-pare-their-five-day-rally">to place tariffs </a>on several sectors, including automotive, semiconductors and pharmaceuticals.
Trump said automotive tariffs would come "in the neighborhood of 25%." A report said the tariffs could come as early as April 2.
Semiconductor and pharmaceutical tariffs would also come around the 25% level and could increase throughout 2025. No date for these tariffs has been announced or planned by Trump and the White House administration.
Trump has targeted China, Canada and Mexico with tariffs or threats of tariffs since taking office in January.
Benzinga recently asked if the tariffs could impact stock market indexes like the S&amp;P 500, which is tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>).
"How will Trump's tariffs affect the stock market?" Benzinga asked.
The results were:
<ul>
<li>Weigh down: 59%</li>
<li>Push higher: 23%</li>
<li>No real impact: 19%</li>
</ul>
The majority of respondents said Trump's tariffs will send the stock market lower. The remaining voters were split nearly even between the stock market going higher as the result of tariffs or the tariffs not having a real impact on stock market returns.
Read Also: <a href="https://www.benzinga.com/news/global/25/02/43442219/why-beer-tequila-avocados-cars-iphone-prices-could-rise-trumps-tariffs-on-canada-mexico-china-to-hurt-several-sectors">Why Beer, Tequila, Avocados, Cars, iPhone Prices Could Rise: Trump&#8217;s Tariffs On Canada, Mexico, China To Hurt Several Sectors</a>
Why It's Important: Trump recently said the White House will go country by country and adjust trade relations with "fair and reciprocal" tariffs.
This process, along with targeting certain specific industries, could see stocks hurt by the impact as costs are passed on to companies and consumers for the trade wars.
&#8220;I&#8217;ve decided, for purposes of fairness, that I will charge a reciprocal tariff, meaning whatever countries charge the United States of America,&#8221; Trump said, as&nbsp;<a href="https://www.nbcnews.com/business/economy/trump-reciprocal-tariffs-what-products-countries-how-much-rcna192075" target="_blank" rel="noreferrer noopener">reported&nbsp;</a>by NBC. &#8220;In almost all cases, they&#8217;re charging us vastly more than we charge them but those days are over.&#8221;
Benzinga<a href="https://www.benzinga.com/news/global/25/02/43712690/exclusive-will-trumps-chinese-tariffs-help-or-hurt-americas-economy-54-say-this"> recently polled readers</a> to see if they think the tariffs on China will be good or bad for the American economy.
&#8220;Will Trump&#8217;s tariffs on China help or hurt the U.S. economy?&#8221; Benzinga asked.
The results were:
<ul>
<li>Hurt businesses and consumers: 54%</li>
<li>Help the economy: 36%</li>
<li>No real impact: 10%</li>
</ul>
The winner of the poll was that tariffs on China will hurt businesses and consumers in America.
While Trump has called the tariff moves a way to fight the trade imbalances, other countries have threatened America with retaliatory measures like tariffs of their own or other measures. The Wall Street Journal said China was looking to target American companies with antitrust concerns. The list of companies China could target includes Nvidia, Apple, Broadcom and Alphabet.
China is now<a href="https://www.benzinga.com/news/global/25/02/43600852/china-sets-sights-on-us-tech-companies-as-trade-tensions-rise" target="_blank" rel="noreferrer noopener">&nbsp;turning its attention&nbsp;</a>to targeting American technology companies with trade relations escalating according to a new report.
The Wall Street Journal said China is looking at targeting American tech companies with antitrust concerns in the country. The list of companies China could target includes Nvidia, Apple, Broadcom and Alphabet. &nbsp;
A previous&nbsp;<a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43041374/exclusive-how-high-will-sp-500-go-under-donald-trump-in-2025-readers-are-optimistic-26-say-this" target="_blank" rel="noreferrer noopener">Benzinga reader survey</a>&nbsp;asked how high investors thought the SPY could go in 2025, Trump&#8217;s first year back in the White House.
In 2017, the SPDR S&amp;P 500 ETF Trust was up 21.7%. This was the first year with Trump in office and many sectors saw gains during the year.
When asked what they thought the return of the SPY would be in 2025, these were the results:
<ul>
<li>16%+: 26%</li>
<li>11% to 15%: 22%</li>
<li>Will Decline: 22%</li>
<li>6% to 10%: 19%</li>
<li>0% to 5%: 12%</li>
</ul>
The poll found that the largest percentage believed that the S&amp;P 500 Index would post gains of at least 16% in 2025. The 11% to 15% range came in second place at 22%.
It's also worth pointing out that the S&amp;P 500 decline in 2025 was tied for second in the poll at 22%. This could mean 2025 is a make-or-break year.
SPY Price Action: The SPDR S&amp;P 500 ETF Trust trades at $611.79 on Wednesday versus a 52-week range of $493.56 to $611.96, a new high hit earlier in Wednesday&#8217;s trading session. The ETF is up 23.2% in the past year. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/02/43795579/warren-buffett-unfazed-by-trumps-tariff-threats-oracle-of-omaha-bets-on-mexico-beer">Warren Buffett Unfazed By Trump&#8217;s Tariff Threats: Oracle Of Omaha Bets On Mexico, Beer</a></li>
</ul>
The study was conducted by Benzinga from Feb. 11, 2025 through Feb. 12, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 119 adults.
Image: Shutterstock

EXCLUSIVE: Will Trump's Tariffs Hurt Or Help Stock Market? 59% Say This…

In the current session, the stock is trading at $16.96, after a 0.53% spike. Over the past month, Upwork Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) stock increased by 11.51%, and in the past year, by 36.45%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1739994318_0.png" alt="Past Year Chart" />

<h3>How Does Upwork P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Upwork has a lower P/E than the aggregate P/E of 108.1 of the Professional Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1739994318_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

UPWK

Price Over Earnings Overview: Upwork

Rivian Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) will be reporting its fourth-quarter earnings on Thursday. Wall Street expects a loss of 65 cents per share and $1.40 billion in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=RIVN" target="_blank" rel="noreferrer noopener"> after market hours</a>.
The stock is down 11.42% over the past year, up 6.23% YTD.
Let&#8217;s look at what the charts indicate for Rivian stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com//node/43615392">Rivian To Hike R1T, R1S Prices In Canada By Nearly 10% From Feb 25 Amid Exchange Rate Shift</a>
<h2 class="wp-block-heading">Rivian Stock Strongly Bullish Ahead Of Q4 Earnings</h2>
Rivian stock is displaying strong bullish momentum, with its share price currently trading above key moving averages. The stock is positioned above its five-day, 20-day and 50-day exponential moving averages, indicating sustained buying pressure. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="629" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19133658/Screenshot-2025-02-20-at-12.04.36-AM.png" alt="" class="wp-image-789671" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19133658/Screenshot-2025-02-20-at-12.04.36-AM.png 629w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19133658/Screenshot-2025-02-20-at-12.04.36-AM-300x233.png 300w" sizes="(max-width: 629px) 100vw, 629px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022025&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
At $14.11, Rivian stock is well above its eight-day simple moving average of $13.28, its 20-day simple moving average of $12.91 and its 50-day simple moving average of $13.56, all reinforcing a bullish trend. 
Additionally, the stock remains above its 200-day simple moving average of $12.63, confirming strength in the long-term uptrend.
Momentum indicators also support the bullish outlook. The Moving Average Convergence Divergence (MACD) indicator stands at 0.12, signaling positive momentum. Meanwhile, Rivian stock's Relative Strength Index (RSI) is at 58.51, suggesting the stock is nearing overbought levels but still has room for further gains. 
As long as Rivian stock holds above these key technical levels, the bullish trend remains intact.
<h2 class="wp-block-heading">Rivian Analysts See 2% Downside</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/RIVN/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on Rivian stock stands at a Buy currently with a price target of $15.87. The latest analyst ratings from Barclays, UBS and Truist Securities give Rivian a $14 target.
RIVN Stock Price Action: Rivian stock was down 2.39% at $14.11 at the time of publication Wednesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com//node/43806303">Tesla-Rival Rivian&#8217;s $6.6 Billion Federal Loan Under Scrutiny As Trump Administration Reviews Funding</a></li>
</ul>
Photo: Shutterstock

Tech

RIVN

Rivian's Technical Setup Signals Strength Ahead Of Q4 Earnings

Shares of nuclear components and fuel supplier BWX Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) are<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> trading higher </a>on Wednesday.
The company has been awarded contracts totaling approximately $2.1 billion from the U.S. <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43809100/bwxt-announces-2-1-billion-in-contracts-for-naval-nuclear-reactor-components" rel="noreferrer noopener">Naval Nuclear Propulsion Program</a>.
These agreements are centered on manufacturing reactor components for the Columbia and Virginia class submarines, along with Ford class aircraft carriers.
The work will be carried out at multiple BWX Technologies facilities in Lynchburg, Virginia, Barberton and Euclid, Ohio, and Mount Vernon, Indiana, over a seven-year period beginning in 2023.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/legal/25/02/43778605/tesla-files-fresh-lawsuit-against-matthews-after-court-defeat" rel="noreferrer noopener">Tesla Files Fresh Lawsuit Against Matthews After Court Defeat</a>
Alongside the reactor component contracts, BWX Technologies is also responsible for manufacturing nuclear fuel. This contract, valued at around $300 million, was awarded and announced in October 2023. The project is slated for completion by the end of this year.
&#8220;For more than 70 years, BWXT has proudly supported the U.S. Navy&#8217;s mission to defend freedom and uphold security across the globe,&#8221; said BWXT Nuclear Operations Group, Inc. president Gary D. Camper.
&#8220;These contracts represent not just our unmatched expertise in naval nuclear power but also our dedication to empowering the Navy with the tools needed to ensure the seas remain free and open.&#8221;
Price Action: BWXT shares are trading higher by 2.44% at $109.34 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43791589/why-is-uber-stock-trading-higher-on-tuesday" target="_blank" rel="noreferrer noopener">Uber&#8217;s Ski Service Launches Across Europe: Details</a></li>
</ul>
Image via Shutterstock.

Contracts

BWXT

What's Going On With BWX Technologies Stock Today?

Celsius Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NYSE">CELH</a>) short percent of float has risen 18.37% since its last report. The company recently reported that it has 37.19 million shares sold short, which is 20.49% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.23 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Celsius Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739993426_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Celsius Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Celsius Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Celsius Holdings's peer group average for short interest as a percentage of float is 5.31%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CELH

What Does the Market Think About Celsius Holdings?

Toll Brothers's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) short percent of float has risen 29.53% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 4.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.22 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Toll Brothers Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739993421_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Toll Brothers has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Toll Brothers's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Toll Brothers's peer group average for short interest as a percentage of float is 10.27%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Toll Brothers?

MetLife's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) short percent of float has fallen 8.53% since its last report. The company recently reported that it has 6.80 million shares sold short, which is 1.18% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>MetLife Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739993415_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for MetLife has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing MetLife's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, MetLife's peer group average for short interest as a percentage of float is 2.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Do Investors Really Feel About MetLife?

<a href="https://www.benzinga.com/topic/george-soros">Billionaire investor George Soros</a> made some bold portfolio adjustments in the fourth quarter, signaling a shift toward growth while easing off defensive bets. 
Soros Fund Management's latest 13F filing shows fresh bets on Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) and small-cap stocks, alongside a significant reduction in its SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) put position.
Meanwhile, the fund trimmed its stake in Alibaba Group Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABAF#NYSE">BABAF</a>) and fully exited Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), reflecting a shifting stance on Chinese tech.
<h2 class="wp-block-heading">Doubling Down On Alphabet, Small Caps</h2>
Alphabet emerged as one of Soros' biggest buys, with the fund increasing its stake by 2.55%. 
The firm also ramped up its exposure to the iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), a play on smaller, high-growth companies. 
This move suggests Soros is betting on a continued rebound in both mega-cap tech and smaller, more volatile stocks.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43816112/hedge-fund-shake-up-tiger-appaloosa-soros-outperform-buffett-icahn-ackman">Hedge Fund Shake-Up: Tiger, Appaloosa, Soros Outperform Buffett, Icahn, Ackman</a>
<h2 class="wp-block-heading">Cutting Market Hedges, Adding Fixed Income</h2>
Soros Fund slashed its SPY put position by nearly 15%, signaling reduced bearish sentiment on the broader market. &#8216;
The fund also trimmed holdings in The Financial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) and iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>), while increasing exposure to Ford Motor Co&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) debt and the iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) calls — moves that hint at an evolving fixed-income strategy.
<h2 class="wp-block-heading">China Exposure Shrinks As BABA Gets Trimmed</h2>
Alibaba stock took a hit in the fourth quarter as Soros scaled back his position, joining other investors in reassessing Chinese tech. 
Meanwhile, Smurfit WestRock PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>) remained the fund's top holding at 5.71% of the portfolio, with Alphabet and AstraZeneca PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) rounding out the top three.
Soros' latest moves suggest a more optimistic take on U.S. growth stocks while pulling back on market hedges and Chinese tech bets.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43811538/5-top-tech-stocks-hedge-funds-have-been-bullish-on-in-q4-hint-its-not-nvidia">5 Top Tech Stocks Hedge Funds Have Been Bullish On In Q4 (Hint: It&#8217;s Not Nvidia)</a></li>
</ul>
Image: Shutterstock

Long Ideas

Hedge Funds

BABA

ALIBABA GROUP HOLDING LTD by Alibaba Group Holding Limited

BABAF

GOOGL

ORCL

iShares Trust Barclays 20+ Year Treasury Bond Fund

George Soros Makes Fresh Bets On Alphabet, Small Caps: What About SPY Puts And Alibaba?

On Wednesday, Precision BioSciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) revealed initial results from the first administration of PBGENE-HBV in cohort 1, the lowest dose level <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43808780/precision-biosciences-announces-initial-safety-and-antiviral-activity-of-pbgene-hbv-in-the-elimina" rel="noreferrer noopener">of the ELIMINATE-B trial</a>.
The ELIMINATE-B trial is designed to investigate PBGENE-HBV at multiple ascending dose levels with three dose administrations per dose level in chronic Hepatitis B patients who are HBeAg-negative.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42924720/precision-biosciences-gene-editing-platform-has-differentiated-mechanism-and-is-potentially-competitive-analyst" rel="noreferrer noopener">Precision BioSciences&#8217; Gene Editing Platform Has Differentiated Mechanism, And Is Potentially Competitive: Analyst</a>
PBGENE-HBV, which comprises an ARCUS-encoding mRNA encapsulated in a lipid nanoparticle (LNP), was safe and well tolerated in all three cohort 1 participants after the first administration of a 0.2 mg/kg dose. The planned dosing schedule in ELIMINATE-B allows for two additional administrations at this dose level while simultaneously investigating the next higher dose level.
Across the three participants dosed, none experienced a Grade ≥2 treatment-related adverse event or serious adverse event.
In addition to safety, PBGENE-HBV demonstrated a substantial reduction in Hepatitis B surface antigen (HBsAg) in two of the three participants following the first administration at dose level 1.
With a well-tolerated safety profile and early antiviral activity established at pre-specified time points, Precision will complete subsequent administrations in all cohort 1 patients.
The ELIMINATE-B study is currently enrolling HBeAg-negative chronic Hepatitis B patients at sites in Moldova, Hong Kong, and New Zealand.
The company is on schedule to provide additional administrations at this dose level and subsequently plans to escalate to higher dose levels to define the optimal dose and number of dose administrations for safely eliminating covalently closed circular DNA (cccDNA)&nbsp;and inactivating integrated HBV DNA.
Precision plans to share detailed clinical data throughout 2025. HC Wainwright analyst Patrick Trucchio reiterates Precision BioSciences with a Buy and maintains a $60 price target.
Price Action: DTIL stock is up 9.22% at $5.63 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/25/02/43817640/philips-stock-falls-as-china-weakness-drags-q4-earnings-2025-outlook" target="_blank" rel="noreferrer noopener">Philips Stock Falls As China Weakness Drags Q4 Earnings, 2025 Outlook</a></li>
</ul>

Biotech

DTIL

Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate

BlackRock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) shares are trading <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">relatively flat on Wednesday.</a>
The company has reportedly canceled meetings with companies amid U.S. Securities and Exchange Commission&#8217;s new investor activism rules, raising concerns over the future of environmental, social, and governance engagement, The Financial Times <a target="_blank" href="https://www.ft.com/content/533f9322-f098-4b82-823f-a7a8ef9350f1" rel="noreferrer noopener">reports</a>.
The SEC&#8217;s recent rule changes, which target the influence of ESG factors in investing, have forced BlackRock to pause its usual &#8220;stewardship&#8221; meetings while it assesses the new regulatory landscape, the report adds, citing people familiar with the discussions.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, BLK stock has gained over 22% in the past year. Investors can gain exposure to the stock via&nbsp;Fidelity Disruptive Finance ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDFF#NASDAQ">FDFF</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43816112/hedge-fund-shake-up-tiger-appaloosa-soros-outperform-buffett-icahn-ackman" rel="noreferrer noopener">Hedge Fund Shake-Up: Tiger, Appaloosa, Soros Outperform Buffett, Icahn, Ackman</a>
The SEC&#8217;s updated guidelines impose more stringent requirements on fund managers who aim to influence corporate behavior, such as pressing for changes in executive compensation or promoting climate risk disclosures.
Previously, managers owning more than 5% of a company could file a relatively simple 13-G form, but now they may need to file a 13-D, triggering more complex disclosures and deadlines.
This regulatory shift complicates BlackRock&#8217;s ability to engage on key ESG topics and undermines efforts to address corporate governance issues like poison pill plans, the report further notes.
The rule changes have drawn criticism for curbing the power of fund managers to press companies on social and environmental issues, especially as conservative lawmakers intensify pressure on firms like BlackRock over their perceived influence on corporate America.
As BlackRock and other asset managers navigate these new requirements, the broader impact on ESG investing and corporate governance remains unclear.
Price Action: BLK shares are trading higher by 0.86% to $986.23 at last check Wednesday.
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43766008/berkshire-hathaways-13f-filing-suggests-a-buffett-style-bash-pizza-beer-and-fine-wine" target="_blank" rel="noreferrer noopener">Berkshire Hathaway&#8217;s 13F Filing Suggests a Buffett-Style Bash — Pizza, Beer and Fine Wine</a></li>
</ul>
Photo by rafapress on Shutterstock.

Media

FDFF

What's Going On With BlackRock Stock Today?

On Wednesday, Harmony Biosciences Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRMY#NASDAQ">HRMY</a>) received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for pitolisant for excessive daytime sleepiness (EDS) in adult patients <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43810390/harmony-biosciences-provides-update-on-the-status-of-the-supplemental-new-drug-application-for-pit" rel="noreferrer noopener">with idiopathic hypersomnia (IH)</a>.
Harmony&#8217;s 2025 net revenue guidance of $820 million-$860 million remains unchanged.
&#8220;We are disappointed with this short-term setback, but our long-term strategy for pitolisant in IH remains firmly on track with our focus on Pitolisant HD,&#8221; said Jeffrey M. Dayno, President and Chief Executive Officer of Harmony Biosciences. &#8220;We are on track to initiate a Phase 3 registrational trial of Pitolisant HD in IH in Q4 2025, with a target PDUFA date in 2028.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40802152/neurology-focused-harmony-biosciences-gains-confidence-with-wakix-sales-surge-strat" rel="noreferrer noopener">Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says</a>
Although the primary outcome for excessive daytime sleepiness (EDS) between pitolisant and placebo did not reach statistical significance in the randomized withdrawal phase of the Phase 3 INTUNE Study, the data from the open-label phase showed that patients experienced improvements on the Epworth Sleepiness Scale that were five times greater than what is recognized as clinically meaningful.
Furthermore, most patients in the long-term extension study achieved normal levels of wakefulness and sustained this response beyond one year.
Pitolisant is marketed as Wakix&nbsp;in the U.S. for EDS or cataplexy in adult patients with narcolepsy and for EDS in pediatric patients 6 years of age and older with narcolepsy.&nbsp;It is not currently approved for IH.
In January, the company reported preliminary net product revenue for the fourth quarter of approximately $201 million, compared to $168.4 million a year ago and the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $198.6 million</a>.
The average number of patients on Wakix increased by approximately 300 sequentially to approximately 7,100 for the quarter <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42942961/harmony-biosciences-reports-strong-2024-revenues-provides-2025-revenue-guidance-and-highlights-key" rel="noreferrer noopener">ended December 31, 2024</a>.
Needham analyst Ami Fadia maintains Harmony Biosciences with a Buy and lowers the price <a target="_blank" href="https://www.benzinga.com/quote/HRMY/analyst-ratings" rel="noreferrer noopener">target from $52 to $50</a>.
Price Action: HRMY stock is down 6.50% at $36.55 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43815970/ai-meets-water-palantir-partners-with-saur-for-smarter-contract-management" target="_blank" rel="noreferrer noopener">Palantir Strikes AI Deal With SAUR For Contract Management: Details</a></li>
</ul>

HRMY

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder

Press Releases

AdaptHealth Corp. to Participate in the Baird 2024 Global Healthcare Conference

AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity and Reduced Cost of Debt

Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer

AdaptHealth Corp. Announces Third Quarter 2024 Earnings Release Date and Conference Call

AdaptHealth Appoints Diana Nole to Board of Directors

AdaptHealth Corp. Announces Third Quarter 2024 Results

AdaptHealth Corp. to Participate in the Stifel 2024 Healthcare Conference

AdaptHealth Corp. to Participate in the BofA Securities Home Care Conference 2024

AdaptHealth Corp. Announces Appointment of Russell Schuster as Chief Commercial Officer

AdaptHealth Corp. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call

Comments

AdaptHealth

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga